NORMAL HUMAN SERUM ALBUMIN
Hypoalbuminemia
Healthgen Biotechnology Corp.protein_peptidePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Hypoalbuminemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Osrhsa Healthgen Biotechnology Corp. | Phase 3 | BB |
Pentoxiphylline Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 3 | BB |
Alpha Tocopherol University of Ioannina | N/A | D |
L-AMINO ACIDS University of Ioannina | N/A | D |
Same molecule, other indications
NORMAL HUMAN SERUM ALBUMIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →